UPPER-BOUNDS FOR TYPE-I AND TYPE-II ERROR RATES IN CONDITIONAL POWER CALCULATIONS

被引:33
作者
DAVIS, BR [1 ]
HARDY, RJ [1 ]
机构
[1] UNIV TEXAS,SCH PUBL HLTH,HOUSTON,TX 77030
基金
美国国家卫生研究院;
关键词
EARLY STOPPING; DATA MONITORING; STOCHASTIC CURTAILMENT; TYPE-I ERROR AND TYPE-II ERROR;
D O I
10.1080/03610929008830398
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
Stochastic curtailment procedures are used to monitor accumulating data in long term clinical trials. These procedures allow one to calculate the conditional probability under H(0) (or alternative hypothesis, H(a) given current data, of rejecting (accepting) H(0) at the end of the trial. One might stop early and reject (accept) H(0) if this probability is equal to or greater than gamma (gamma'). Lan, Simon and Halperin (1982) have shown that if alpha and beta are the type I and type II errors, respectively, then the type I (type II) error using a stochastic curtailment method is equal to or less than alpha/gamma (beta/gamma'). This upper bound is based on an unlimited number of interim looks. In fact, there are usually a small number of looks. Lower upper bounds using only the standard normal distribution table are presented. A computer program to obtain these bounds is available from the authors.
引用
收藏
页码:3571 / 3584
页数:14
相关论文
共 21 条
  • [1] CLOSED SEQUENTIAL TESTS FOR BINOMIAL PROBABILITIES
    ALLING, DW
    [J]. BIOMETRIKA, 1966, 53 : 73 - &
  • [2] EARLY DECISION IN WILCOXON 2-SAMPLE TEST
    ALLING, DW
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1963, 58 (303) : 713 - +
  • [3] REPEATED SIGNIFICANCE TESTS ON ACCUMULATING DATA
    ARMITAGE, P
    MCPHERSO.CK
    ROWE, BC
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-GENERAL, 1969, 132 : 235 - &
  • [4] BERRY DA, 1985, STAT MED, V4, P521, DOI 10.1002/sim.4780040412
  • [5] Breiman L., 1968, PROBABILITY
  • [6] DAVIS BR, 1988, 1988 M SOC CLIN TRIA
  • [7] STATISTICAL ASPECTS OF EARLY TERMINATION IN THE BETA-BLOCKER HEART ATTACK TRIAL
    DEMETS, DL
    HARDY, R
    FRIEDMAN, LM
    LAN, KKG
    [J]. CONTROLLED CLINICAL TRIALS, 1984, 5 (04): : 362 - 372
  • [8] MONITORING VERSUS INTERIM ANALYSIS OF CLINICAL-TRIALS - A PERSPECTIVE FROM THE PHARMACEUTICAL-INDUSTRY
    ENAS, GG
    DORNSEIF, BE
    SAMPSON, CB
    ROCKHOLD, FW
    WUU, J
    [J]. CONTROLLED CLINICAL TRIALS, 1989, 10 (01): : 57 - 70
  • [9] EARLY DECISION IN A CENSORED WILCOXON 2-SAMPLE TEST FOR ACCUMULATING SURVIVAL DATA
    HALPERIN, M
    WARE, J
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1974, 69 (346) : 414 - 422
  • [10] AN AID TO DATA MONITORING IN LONG-TERM CLINICAL-TRIALS
    HALPERIN, M
    LAN, KKG
    WARE, JH
    JOHNSON, NJ
    DEMETS, DL
    [J]. CONTROLLED CLINICAL TRIALS, 1982, 3 (04): : 311 - 323